Section Arrow
CVRX.NASDAQ
- CVRx
Quotes are at least 15-min delayed:2025/06/28 14:58 EDT
Last
 5.82
-0.05 (-0.85%)
Day High 
5.97 
Prev. Close
5.87 
1-M High
7.17 
Volume 
251.23K 
Bid
5.26
Ask
6.1
Day Low
5.79 
Open
5.88 
1-M Low
5.54 
Market Cap 
153.05M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.85 
20-SMA 6.21 
50-SMA 6.44 
52-W High 18.55 
52-W Low 4.2993 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.14/-1.94
Enterprise Value
203.20M
Balance Sheet
Book Value Per Share
2.66
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
51.29M
Operating Revenue Per Share
1.35
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed:2025/06/28 14:58 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.